The mouse Anxa6/miR-9-5p/Anxa2 axis modulates TGF-β1-induced mouse hepatic stellate cell (mHSC) activation and CCl4-caused liver fibrosis
Authors:
- 25 April 2022
- journal article
- research article
- Published by Elsevier in Toxicology Letters
- Vol. 362, 38-49
Abstract
No abstract availableKeywords
Funding Information
- Hunan Provincial Natural Science Foundation
This publication has 35 references indexed in Scilit:
- Clinical evidence for the regression of liver fibrosisJournal of Hepatology, 2012
- Beyond “Cirrhosis”American Journal of Clinical Pathology, 2012
- Role of miRNA in distinguishing primary brain tumors from secondary tumors metastatic to the brainFrontiers in Bioscience-Scholar, 2011
- Subcellular proteome analysis unraveled annexin A2 related to immune liver fibrosisJournal of Cellular Biochemistry, 2010
- Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organJournal of Clinical Investigation, 2007
- The Role of Focal Adhesion Kinase-Phosphatidylinositol 3-Kinase-Akt Signaling in Hepatic Stellate Cell Proliferation and Type I Collagen ExpressionJournal of Biological Chemistry, 2003
- DDR2 receptor promotes MMP-2–mediated proliferation and invasion by hepatic stellate cellsJournal of Clinical Investigation, 2001
- Matrix as a Modulator of Hepatic FibrogenesisSeminars in Liver Disease, 2001
- A Phosphatidylinositol 3-Kinase/Akt Pathway, Activated by Tumor Necrosis Factor or Interleukin-1, Inhibits Apoptosis but Does Not Activate NFκB in Human Endothelial CellsJournal of Biological Chemistry, 2000
- Matrix adhesion and Ras transformation both activate a phosphoinositide 3‐OH kinase and protein kinase B/Akt cellular survival pathwayThe EMBO Journal, 1997